We are live on ! Find out more
PIII icon

P3 Health Partners

33 hedge funds and large institutions have $2.9M invested in P3 Health Partners in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

1.63% less ownership

Funds ownership: 12.42% → 10.79% (-1.6%)

11% less funds holding

Funds holding: 37 → 33 (-4)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

64% less capital inflows, than outflows

Capital inflows: $306K | Capital outflows: $851K

Holders
33
Holders Change
-4
Holders Change %
-10.81%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
8
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

PIII Hedge Fund Activity: Q1 2025 in Review

33 of the 7,490 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q1 2025, worth a combined $2.9M — down 37% from $4.57M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of PIII and 4 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 8 added.

The largest buyer was Corient Private Wealth, adding an estimated $118K. The largest seller was Alyeska Investment Group, cutting an estimated $564K.

  • 33 institutional investors held P3 Health Partners (PIII) as of Q1 2025, down from 37 in Q4 2024.
  • Funds reported $2.9M of P3 Health Partners stock for Q1 2025, down 37% quarter-over-quarter.
  • 4 funds opened new P3 Health Partners positions in Q1 2025 and 8 closed out, a net change of -4 holders.
  • The largest P3 Health Partners buyer in Q1 2025 was Corient Private Wealth, an estimated $118K added.
  • The largest P3 Health Partners seller in Q1 2025 was Alyeska Investment Group, an estimated $564K sold.

Based on aggregated 13F filings for Q1 2025.